Not So Different: What the Generics Industry Can Tell Us About the Future of Biosimilars
Season 4, Episode 17, Jul 18, 2021, 11:00 AM
On this week’s episode, we sat down with David Senior, senior vice president of Market Economics at AmerisourceBergen. We discussed how the generics market developed in the United States and some of the challenges that it faced. We also talked about how the US generics industry could be instructive in understanding how biosimilar sales may develop over time.
To learn more about the Hatch-Waxman Act, click here.
To learn more about how biosimilars compare with the generics market, click here.
To learn more about the challenges that both the biosimilars and generic markets face, click here.